NCT06624059
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06624059
Title A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC) (HORIZON 2)
Acronym HORIZON 2
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA | BRA | AUS

Facility Status City State Zip Country Details
Royal North Shore Hospital St Leonards New South Wales 2065 Australia Details
Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia Details
Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo São Paulo 01246-000 Brazil Details
RedSalud Vitacura Santiago Chile Details
Beijing Cancer Hospital Beijing 100142 China Details
The third people's hospital of Chengdu Chengdu China Details
Guangdong General Hospital Guangzhou 510000 China Details
Jinhua municipal central hospital Jinhua China Details
Yunnan Cancer Hospital Kunming 650118 China Details
Institut Gustave Roussy Villejuif 94805 France Details
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia Perugia Umbria 06156 Italy Details
Asan Medical Center Seoul 05505 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field